chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccination of anthrax on/about 1/26/03, 3rd shot. Rash developed 4 days later. C/O itching. Has diffuse erythematous, urticarial-like lesions on upper torso measuring at 2x3mm. Punch bx taken, sent in. Pt given Atarax 25mg tid, aveeno and Sarna lotion. Derm consult put in.
Inappropriate schedule of vaccine administered; COVID-19; Fatigue aggravated; Arthralgia aggravated; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), FATIGUE (Fatigue aggravated), ARTHRALGIA (Arthralgia aggravated) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Drug allergy (PLAQUENIL) and Drug allergy (REGLAN). Concomitant products included VITAMIN D3 and CALCIUM, COLECALCIFEROL (CALCIUM 500+D) for an unknown indication.   In September 2019, the patient UPADACITINIB (RINVOQ) (Oral) dosage was changed to 15 milligram. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, UPADACITINIB (RINVOQ) (Oral) dosage was changed to 5 milligram. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) 7.5 milligram. In June 2021, the patient experienced COVID-19 (COVID-19). In 2021, the patient experienced FATIGUE (Fatigue aggravated) and ARTHRALGIA (Arthralgia aggravated). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). In 2021, COVID-19 (COVID-19) had resolved. At the time of the report, FATIGUE (Fatigue aggravated) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown and ARTHRALGIA (Arthralgia aggravated) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, SARS-CoV-2 test: (Positive) Positive.         This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. No treatment medication was provided. The reporter's causality of rinvoq for the events of COVID-19, More fatigue increase joint pain, patient afraid would run out of rinvoq prior receiving and spacing out pills to one pill every other day to every three days was not provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.
Information has been received from a health professional concerning a 29 year old white female with stomach pain, juvenile diabetes and allergy to erythromycin who on 12-DEC-2005 was vaccinated into right deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot#650583/0746P).  On 12-DEC-2005 the patient developed severe pain in the right shoulder, collar bone, into neck and down arm.  The patient was advised treatment with ice and ibuprofen.  It was reported on 15-DEC-2005, that the patient's neck pain resolved.  The pain in right shoulder, collar bone and arm persisted.  No further information is available.
pt recv vax 16SEP96 & exp nausea, t101.7-102;20SEP96 dec appetite, palmer sized local macular rash rt waist area;skin otherwise clear;no enlarged nodes or joints;
upper arm swelled for a few days then subsided;however, it is still sore & weak when doing certain exercises;
since being vaccinated for 4-5 weeks pt experienced on and off headaches, nausea, fogginess and fatigue.    Denies any peripheral edema, bruising, petechiae, SOB, chest pain, vision changes, or abd pain.
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date).    No concomitant medication was reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-Significant Live Followup; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
high fever; chest tightness; Vicious vomiting; left eye swelling; restlessness; body aches; headache; difficulty breathing; difficulty speaking; shortness of breath; This is a spontaneous report from a contactable consumer (patient).   This 25-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN7206) at the age of 25 years, via an unspecified route of administration at single dose in the left arm on 07Mar2021 10:00 AM for COVID-19 immunisation. Medical history included asthma. Concomitant medications included salbutamol (ALBUTEROL HFA), lansoprazole (PREVACID), both taken for an unspecified indication. Previously the patient received the first dose of BNT162B2 (Lot Number: EL9266) at the age of 25 years on 13Feb2021 10:00 AM in the left arm for COVID-19 immunisation. On 07Mar2021 23:00,  the patient experienced high fever, chest tightness, vicious vomiting, left eye swelling, restlessness, body aches, headache, difficulty breathing, difficulty speaking, shortness of breath. No treatment required. The events required a visit to the physician's office. The outcome of the events was not recovered. The vaccine was administered at a Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination.
Evening of 08/28/02, mother reported the child ran a temperature of 101 degrees F, Resolved next am,  On 09/12/02 left arm tender, red, swollen, ands warm to touch. Scab at site, Seen at doctor's office by nurse practitioner  Further information states "PHN spoke with nurse in doctor's office to obtain information related to treatment and recovery. The nurse states that notes in the chart indicate the area affected measured 2 cm by 3 cm. Keflex was ordered in addition to warm soaks. A follow up appointment was scheduled for Monday 09/16/02. PHN attempted to reach the office by phone on several occasions. On Friday, 09/20/02, I spoke with a RN at doctor's office who indicated that another follow uo appointment is scheduled for 09/23/02. She was unable to give any further information.
pt recvd 3 doses of Engerix-B & when tested, Hep B surface antibody was neg; non immune;
Patient received an improperly stored vaccine; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, allergies, drug reactions, concomitant therapies or medical history provided. On 19-OCT-2020, the patient was vaccinated with one dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T009929, expiration date: 16-SEP-2021, albumin status: rHa) (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis. The temperature to which the vaccine was exposed was -6.6 degrees of Celsius (C) and the time frame was reported as 1 hour and 45 minutes. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA010299: US-009507513-2010USA010348:
Patient presented for this hospitalization with several days of nausea, poor appetite and shortness of breath the day of admission.  Staff consulted and felt the  sepsis not to be of intra-abdominal, or perirectal/perineal etiology. She should continue with the previously arranged colorectal surgery clinic follow up regarding seton placed for a fistula found from her necrotizing infection. The mild DKA and the AKI with which she presented have resolved. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
don't know if it was a true reaction patient turned red at injection spots could be from when held down
injection site noted to be pink, with swelling  up to 2 cm , 7 days after injection.
sore arm; Agree to delete the cases US2023AMR060547 (reporter's case) and US2023AMR060554 (husband's case) as cases created in error. It is ok to keep one suspect with blank dose number. As it is not clear after which dose event occur and to retain only one case' please explain in narrative.; Sender's Comments:  US-GSK-US2023AMR060545:same reporter US-GSK-US2023AMR060547:deletion case US-GSK-US2023AMR060553:Same reporter
ITP (Idiopathic Thrombocytopenic Purpura) developed 2 days after vaccination.
Approximately 12 hours after receiving my Covid vaccination, I experienced onset of severe pharyngitis and BL earache along with severe swelling of the glands in my neck and jaw.  I developed a severe headache, photophobia and BL eye pain.  I developed lesions and ulcerations on the skin surrounding my mouth.  My lips cracked and developed blisters and ulcerations.  I developed intra-oral and buccal lesions and ulcerations. I developed nausea and severe diarrhea.  Severe myalgia, skin sensitivity and fatigue.  Later in the day on 12/19/2020, I developed changes in my sense of taste and smell.  Everything had a metallic or "coppery" taste, and my sense of smell was diminished.  The next day, 12/20/2020, the disturbances in taste and smell worsened.    The symptoms were severe on Saturday 12/19/2020 and  Sunday 12/20/2020, and have begun to improve today--Monday 12/21/2020.  No further skin or oral lesions, blisters or ulcerations, and the existing lesions are now healing.  Continued diarrhea and GI upset.  Other symptoms are improving.
1 day after felt tired and achy, slept all day, day 2 broke out in hives all over body, 1 dose of Prednisone not helpful, 2 dose of prednisone helpful still on prednisone.
On upper left arm erythematous, indurated and warm covering top half of left upper arm and going around to sides. started 1 day after immunizations.
red, raised, pimp rash to chest and back 2 days after injection continued up neck and face 1 week into rash. 2 weeks into rash was suggested to use nizoral anti-dandruff shampoo and let set for 5 mins. 2-3 days later rash was resoved.
I95.9 HYPOTENSION 11/4/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R09.02 HYPOXIA 10/30/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
My lymph nodes near my clavicle on my left side have been extremely swollen for almost three months. I am also experiencing extreme fatigue. I have had multiple doctor's visits, bloodwork, and an ultrasound because of it.
This vaccine was used after BUD. Parent did not report any  adverse reaction  after receiving  this vaccine.
Feel like I?ve been  hit by  a truck .  Muscles extremely sore.  Cold chills , headache
Headache, Myalgia, Fever, chills, fatigue Narraitve:
I have had irregular menstrual cycles my entire post-pubescent life (PCOS). After receiving my last dose in February 2021, I began to receive PMS symptoms (acne, tender breast, increased appetite, mood swings) in June. I?ve never experienced and PMS symptoms prior to receiving the vaccine. July through September 2021, my menstrual has been regular and occurring on a timely basis. This is completely  new to me and I have never experienced regularity.
Dtap site on left thigh. Left thigh erythema 10cm x 9cm itchy mildly tender no induration. Per mom she may have had a similar reaction from her earlier infant vaccines but not like this big.
Had rash , mostly on hands. on top of the hand and wrist had red spots. On palms had tiny blisters , without fluid inside and painful. would have for 2-5 days and would go away. in the last 10 months had these symptoms 5-6 times. The redness was more pronounced right after and pain was worse on palms and fingers.  last couple times there was no redness just painful blisters and lasted 2-3 days only. last time had these symptoms in September, 2021.
Within 5 minutes of receiving covid vaccine #1:  Tingling lips, swollen tongue, swollen lips.  All symptoms resolved in 1hour
This spontaneous report as received from a nurse refers to unknown number of patients. On an unknown date the patients received improperly stored GARDASIL (dose, route and lot# not reported). The GARDASIL doses were exposed under the recommended temperature for total of 42 hours and the coldest temperature was 24F. No adverse effect reported. Additional information has been requested.
Pt recvd 3 doses of Engerix-B & had neg titer;
shingles; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 13-FEB-2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a healthcare provider at a physician office for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The lawyer considered shingles to be related to zoster vaccine live (ZOSTAVAX).
red, flat rash over neck & down back @ awakening time 3FEB93; was fussy 2FEB93; came to office 950AM; red rash over chest, back, buttocks; small amt by rt ear; t97.7, cough, runny nose; walking, eating well; 3FB93 rash worse, t102;
contracted the Covid Virus; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (contracted the Covid Virus) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced COVID-19 (contracted the Covid Virus). At the time of the report, COVID-19 (contracted the Covid Virus) outcome was unknown.            No concomitant medications were reported. Patient's husband was reported that after the moderna vaccine patient contracted the Covid Virus. No treatment medications were reported   This case was linked to US-MODERNATX, INC.-MOD-2023-711790 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-711790:Case for Husband
Tested positive for Covid after receiving Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
This spontaneous report as received from a registered nurse refers to 2 unspecified patients. On an unknown date the patients were vaccinated with GARDASIL (lot #, expiration, dose, route unspecified). On an unknown date the patients experienced dizziness after received GARDASIL. The event outcome was unknown. Additional information has been requested.
This is a spontaneous report from a contactable Health Care Professional  via Pfizer Sales representative. A 22-year-old female patient of an unspecified ethnicity received, on 11May2016 at 04:56 PM, TRUMENBA, Lot. J28923, Expiration date: 01Jun2016, intramuscular, in the left deltoid, at 0.5 ml, single dose. The vaccine was administered at the private physician's office/hospital. The next administration will be in Nov2016. The patient medical history and concomitant medications were not reported. The patient experienced fever, chills, body aches, nausea and swelling and redness at injection site all on 11May2016 with outcome of recovered after 1.5 days, on 13May2016. Emergency room, physician visit, treatment and hospitalization were not required. Follow-up (01Aug2016): New information received from a contactable Health Care Professional includes: patient details, suspect drug details, and reaction data.
Information has been received from a clinical medical assistant referring to patient of unknown age and gender. On 20-JAN-2015 the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX lot K005180, expiration date 10-APR-2016, (dose, frequency, therapy route unspecified). No adverse effects were reported. The outcomes of events reported were unknown. No product quality complaint (PQC) was involved. This is one of the several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning a 51 year old male who had his gallbladder removed years ago and who has no allergies, who on 09/02/2005 was vaccinated with a dose of Hepatitis B virus.  Concomitant vaccine administered on the same day included a dose of Hepatitis A vaccine.  On 09/04/2005, 36 hours later, the patient developed right upper quadrant pain.  It was noted that there was no fever and no loss of appetite.  The liver did not appear to be enlarged.  The patient had pain when he took a deep breath.  At the time of the report the patient had not recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.
Information has been received from a medical assistant concerning a 9 year old female patient who on 12-DEC-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot #657108/0369U). On 14-DEC-2007 the patient experienced an injection site reaction, described as inflamed injection site, injection site swelling and injection site itching. The patient sought unspecified medical attention. There was no product quality complaint. Additional information has been requested. This is one of several reports from the same source. Follow-up information was received which reported that on 12-DEC-2007 the patient with no pre-existing allergies, birth defects or medical conditions was vaccinated subcutaneously in the right thigh with a second dose of VARIAVAX (Oka/Merck) (Lot #657108/0369U). On the same day the patient also received the first dose of HAVRIX (Lot #AHAVB1B2A) and FLUZONE (lot #U2438AA) both given IM in the left thigh. There was no illness at the time of vaccination. On 14-DEC-2007 the patient experienced an injection site reaction in the right thigh, described as inflamed injection site, injection site swelling, itching, redness and hotness. On an unspecified date the patient recovered from the events. Additional information is not expected. This is one of several reports from the same source.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown age and gender. The patients' medical history, current conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with GARDASIL 9 (dose, lot number and expiry date were not reported), intramuscularly. On an unknown date, the patients experienced injection site pain and had a hot lump on the arm. They sought medical attention and contacted the pharmacist. The outcome of the events was unknown. The causality assessment was not provided by the reporter, There was no product quality complaint involved. Additional information has been requested.
There was no adverse event that took place. I talked with my office manager and the Doctor and we have put a three step action plan in place to make sure this never happens again.
Moderate to severe pain in the left deltoid. Redness and swelling in the left deltoid. Left deltoid is warm to the touch.
One day after the Covid-19 Pfizer booster shot, my wife and I noticed that I could not finish a meal - this is extremely unusual for me.  That night, October 14, 2021, I felt flushed before bed and my right arm where the shot was given was VERY sore.  After going to sleep about 09:30pm, I was awakened at about 03:00am with severe chills and shaking all over, with a clammy/sweaty "goose bumped" feeling all over.  Additionally, I felt severe "sciatic-like" pain extending from the middle of both right and left shoulders down both arms, and down my left leg.  This was miserable.  I got out of a sweaty bed and took 3 ibuprofen with a full glass of water, then sitting up until about 4:15am, at which time I went back to bed and slept through until 09:30am on the morning of October 15, 2021.    I felt somewhat normal starting around Noon on October 15, but not "completely right"...my body felt "off" somehow.  Around 10:00pm October 15, I went to bed and was suddenly awakened at 01:30am with SEVERE SWEATING - the whole bed was soaking wet including the pillow - and SEVERE sciatic like pain again shooting down both arms from my shoulders, but not my leg this time.  I also had a mild headache and felt flushed and had dry mouth that I could not "cure" right away.  Again, I took more ibuprofen and then again sat up waiting for the extreme pain to subside, which it did by the time I went to bed again around 03:45am.  I then slept hard and awoke at 10:15am today, Saturday, October 16, 2021.  I still do not feel "right" and at home trying to rest.